eng Science and Education Publishing International Journal of Celiac Disease 2334-3486 2017-08-08 5 3 97 100 10.12691/ijcd-5-3-1 IJCD2017531 article Aaron Lerner aaronlerner1948@gmail.com 1 2 Sandra Neidh?fer 2 Torsten Matthias 2 B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Anti-tissue transglutaminase (tTg) IgA are considered the most frequently used serological marker for celiac disease diagnosis. Despite its recommended leading position by the 2012 ESPGHAN diagnostic criteria, it exposes multiple false positive and negative titers. In view of the critical opinions expressed lately in the literature against the application of those criteria, the bias in the central place occupied by tTg-IgA in the new ESPGHAN CD Diagnostic Guidelines and the emergence of newer serological marker for celiac disease, it is hoped that the revised guidelines will open up the limited, problematic and single Tg2-IgA antibody for other or additional single or combined serological diagnostic markers. http://pubs.sciepub.com/ijcd/5/3/1/ijcd-5-3-1.pdf celiac disease antibody diagnosis tissue transglutaminase neo-epitope microbial transglutaminase